Physician profile
Shareef Mansour
NPI 1063068732
$4,334.77
in general payments reported to CMS, 2019-2025
13 companies · $2,131 in 2025
The $2,131 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $28.57 · 2023: $1,973 · 2024: $201 · 2025: $2,131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,008 · Travel and Lodging: $1,109 · Consulting Fee: $1,093 · Education: $96.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,007.57 |
| Travel and Lodging | $1,109.32 |
| Consulting Fee | $1,092.50 |
| Education | $96.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,440.89 | 2024-2025 | Impella |
| Abbott Laboratories | $1,135.18 | 2023-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Alnylam Pharmaceuticals INC. | $931.90 | 2023-2025 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $200.00 | 2023 | |
| Edwards Lifesciences Corporation | $152.92 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $126.88 | 2023-2025 | Lifevest |
| Endotronix, INC. | $118.52 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Novo Nordisk INC | $96.81 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $31.03 | 2024 | |
| Boston Scientific Corporation | $28.57 | 2022 | |
| Pfizer INC. | $27.13 | 2025 | |
| Impulse Dynamics (USA) INC. | $22.88 | 2023 | Optimizer |
| Itamar Medical INC | $22.06 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shareef Mansour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.